Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2020

01-12-2020 | Public Health | Commentary

Some notes on the use, concept and socio-political framing of ‘stigma’ focusing on an opioid-related public health crisis

Author: Benedikt Fischer

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2020

Login to get access

Abstract

Canada has been home to a longstanding public health crisis related to opioids, including an extensive mortality and morbidity toll in the face of substantive intervention gaps. Recently (2019), two extensive reports from preeminent federal authorities – the Chief Public Health Officer and the Mental Health Commission of Canada – have been tabled with detailed, core focus on the phenomenon of ‘stigma’ and its impacts on substance/opioid use and harms. The reports present extensive descriptions of the nature and effects, as well as a multitude of prescriptions for remedial measures and actions to “stop the cycle of stigma”. Closer reading of the documents, however, suggests substantial conceptual and empirical limitations in the characterization of the – multi-faceted and challenging – nature and workings of ‘stigma’ as a socio-political, structural or individual process or force, specifically as it applies to and negatively affects substance use and related outcomes, primarily the wellbeing of substance users. Concretely, it is unclear how the remedial actions proposed will materially alleviate stigma process and impacts, especially given apparent gaps in the issues examined, including essential strategies – for example, reform of drug user criminalization as a fundamental element and driver of structural stigma - for action that directly relate to the jurisdictions and privileged mandates of the report sources themselves as health and policy leaders. The commentary provides some concrete while subjective notes and observations on the dynamics of stigma as applies to and framed for substance/opioid use, as well as strategies and measures necessary to both tangibly address the material health and wellbeing of substance users, and related forces of stigma, in the distinct context of the opioid crisis in Canada.
Literature
1.
go back to reference Vojtila L, Pang M, Goldman B, Kurdyak P, Fischer B. Non-medical opioid use, harms and interventions in Canada – a 10-year update on an unprecedented and unabating substance use-related public health crisis. Drugs: Educ Prev Policy. 2019;27(2):118–22. Vojtila L, Pang M, Goldman B, Kurdyak P, Fischer B. Non-medical opioid use, harms and interventions in Canada – a 10-year update on an unprecedented and unabating substance use-related public health crisis. Drugs: Educ Prev Policy. 2019;27(2):118–22.
2.
go back to reference Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Measuring the burden of opioid-related mortality in Ontario, Canada. J Addict Med. 2018;12(5):418.PubMedPubMedCentral Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Measuring the burden of opioid-related mortality in Ontario, Canada. J Addict Med. 2018;12(5):418.PubMedPubMedCentral
4.
go back to reference Orpana Heather M, Lang Justin J, George Diana HJ. At-a-glance: the impact of poisoning-related mortality on life expectancy at birth in Canada, 2000 to 2016. Health Promotion Chronic Dis Prev Canada: Res Policy Pract. 2019;39(2):56. Orpana Heather M, Lang Justin J, George Diana HJ. At-a-glance: the impact of poisoning-related mortality on life expectancy at birth in Canada, 2000 to 2016. Health Promotion Chronic Dis Prev Canada: Res Policy Pract. 2019;39(2):56.
6.
go back to reference Mental Health Commission of Canada. Stigma and the opioid crisis: final report. Ottawa: Mental Health Commission of Canada; 2019. Mental Health Commission of Canada. Stigma and the opioid crisis: final report. Ottawa: Mental Health Commission of Canada; 2019.
8.
go back to reference Ross CA, Goldner EM. Stigma, negative attitudes and discrimination towards mental illness within the nursing profession: a review of the literature. J Psychiatr Ment Health Nurs. 2009;16(6):558–67.PubMed Ross CA, Goldner EM. Stigma, negative attitudes and discrimination towards mental illness within the nursing profession: a review of the literature. J Psychiatr Ment Health Nurs. 2009;16(6):558–67.PubMed
9.
go back to reference Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143–55.PubMed Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143–55.PubMed
10.
go back to reference Luoma JB. Substance use stigma as a barrier to treatment and recovery. Addiction medicine. New York: Springer; 2010. p. 1195–215. Luoma JB. Substance use stigma as a barrier to treatment and recovery. Addiction medicine. New York: Springer; 2010. p. 1195–215.
11.
go back to reference Stuart H. Managing the stigma of opioid use. Healthcare management forum. Los Angeles: SAGE publications; 2019. Stuart H. Managing the stigma of opioid use. Healthcare management forum. Los Angeles: SAGE publications; 2019.
13.
go back to reference Stuntz WJ. The pathological politics of criminal law. Mich Law Rev. 2001;100(3):505–600. Stuntz WJ. The pathological politics of criminal law. Mich Law Rev. 2001;100(3):505–600.
14.
go back to reference Weisberg R. Norms and criminal law, and the norms of criminal law scholarship. J Crimial Law Criminol. 2002;93(2):467. Weisberg R. Norms and criminal law, and the norms of criminal law scholarship. J Crimial Law Criminol. 2002;93(2):467.
15.
go back to reference Kerr T, Small W, Wood E. The public health and social impacts of drug market enforcement: a review of the evidence. Int J Drug Policy. 2005;16(4):210–20. Kerr T, Small W, Wood E. The public health and social impacts of drug market enforcement: a review of the evidence. Int J Drug Policy. 2005;16(4):210–20.
16.
go back to reference DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357–e74.PubMedPubMedCentral DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357–e74.PubMedPubMedCentral
17.
go back to reference Rhodes T, Sarang A, Vickerman P, Hickman M. Policy resistance to harm reduction for drug users and potential effect of change. Br Med J. 2010;341:c3439. Rhodes T, Sarang A, Vickerman P, Hickman M. Policy resistance to harm reduction for drug users and potential effect of change. Br Med J. 2010;341:c3439.
20.
go back to reference Fischer B, Jones W, Tyndall M, Kurdyak P. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing-exploratory analyses from Canada. BMC Public Health. 2020;20(1):1–7. Fischer B, Jones W, Tyndall M, Kurdyak P. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing-exploratory analyses from Canada. BMC Public Health. 2020;20(1):1–7.
21.
go back to reference Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ. 2018;362:k3207.PubMedPubMedCentral Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ. 2018;362:k3207.PubMedPubMedCentral
22.
go back to reference Fischer B, Lee A, Vojtila L. ‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis–considerations, options and models towards broad-based implementation. Public Health Pract. 2020;1. Fischer B, Lee A, Vojtila L. ‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis–considerations, options and models towards broad-based implementation. Public Health Pract. 2020;1.
24.
go back to reference Laurence M, Snortum J, Zimring F. Social control of the drinking driver. In: Arzt G, editor. Comparative law. Chicago: The University of Chicago Press; 1988. Laurence M, Snortum J, Zimring F. Social control of the drinking driver. In: Arzt G, editor. Comparative law. Chicago: The University of Chicago Press; 1988.
25.
go back to reference Stuber J, Galea S, Link BG. Stigma and smoking: the consequences of our good intentions. Soc Serv Rev. 2009;83(4):585–609. Stuber J, Galea S, Link BG. Stigma and smoking: the consequences of our good intentions. Soc Serv Rev. 2009;83(4):585–609.
26.
go back to reference Campbell C, Deacon H. Unravelling the contexts of stigma: from internalisation to resistance to change. J Community Appl Soc Psychol. 2006;16(6):411–7. Campbell C, Deacon H. Unravelling the contexts of stigma: from internalisation to resistance to change. J Community Appl Soc Psychol. 2006;16(6):411–7.
27.
go back to reference Fischer B, Varatharajan T, Shield K, Rehm J, Jones W. Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. Drug Alcohol Depend. 2018;189(1):76–9.PubMed Fischer B, Varatharajan T, Shield K, Rehm J, Jones W. Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. Drug Alcohol Depend. 2018;189(1):76–9.PubMed
28.
go back to reference Fischer B, Rehm J, Tyndall M. Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. Can Med Assoc J. 2016;188(17–18):1240–4. Fischer B, Rehm J, Tyndall M. Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. Can Med Assoc J. 2016;188(17–18):1240–4.
29.
go back to reference Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7.PubMedPubMedCentral Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7.PubMedPubMedCentral
30.
go back to reference Mastropietro DJ, Omidian H. Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Dev Ind Pharm. 2013;39(5):611–24.PubMed Mastropietro DJ, Omidian H. Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Dev Ind Pharm. 2013;39(5):611–24.PubMed
31.
go back to reference Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K, Medina-Mora M, et al. Drug policy and the public good (2nd edition). Oxford: Oxford University Press; 2018. Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K, Medina-Mora M, et al. Drug policy and the public good (2nd edition). Oxford: Oxford University Press; 2018.
32.
go back to reference Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2019;10:1.PubMed Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2019;10:1.PubMed
33.
go back to reference Yang L, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378.PubMedPubMedCentral Yang L, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378.PubMedPubMedCentral
34.
go back to reference Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs: Educ Prev Policy. 2013;20(2):85–95. Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs: Educ Prev Policy. 2013;20(2):85–95.
35.
go back to reference Kulesza M, Larimer ME, Rao D. Substance use related stigma: what we know and the way forward. J Addictive Behaviors, Therapy Rehabil. 2013;2(2). Kulesza M, Larimer ME, Rao D. Substance use related stigma: what we know and the way forward. J Addictive Behaviors, Therapy Rehabil. 2013;2(2).
36.
go back to reference Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.PubMed Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.PubMed
37.
go back to reference Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.PubMedPubMedCentral Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.PubMedPubMedCentral
38.
go back to reference Crapanzano K, Vath RJ, Fisher D. Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry. 2014;38(4):420–5.PubMed Crapanzano K, Vath RJ, Fisher D. Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry. 2014;38(4):420–5.PubMed
39.
go back to reference Christie N. Suitable enemy. Bianchi H, Swaaningen Rv, editors. Amsterdam: Free University Press; 1986. Christie N. Suitable enemy. Bianchi H, Swaaningen Rv, editors. Amsterdam: Free University Press; 1986.
40.
go back to reference Eastwood N, Fox E, Rosmarin A. A quiet revolution: drug decriminalisation policies in practice across the globe. United Kingdom: Release - Drugs, The Law & Human Rights; 2016. Eastwood N, Fox E, Rosmarin A. A quiet revolution: drug decriminalisation policies in practice across the globe. United Kingdom: Release - Drugs, The Law & Human Rights; 2016.
Metadata
Title
Some notes on the use, concept and socio-political framing of ‘stigma’ focusing on an opioid-related public health crisis
Author
Benedikt Fischer
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2020
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-020-00294-2

Other articles of this Issue 1/2020

Substance Abuse Treatment, Prevention, and Policy 1/2020 Go to the issue